Fibrocell Science, Inc. Announces New Presentation Time at the UBS Global Life Sciences Conference
Source: Fibrocell Science, Inc.
On weekday Sept 16, 2011, 4:17 pm
EXTON, Pa.–(BUSINESS WIRE)–
Fibrocell Science, Inc. (OTCBB:FCSC.ob – News), a engineering consort convergent
on the utilization of autologous (personalized) radiophone therapies for
aesthetic, scrutiny and technological applications, declared today that its
show at the UBS Global Life Sciences Conference to be held on
Sept 19-21, 2ዋ at the Grand Hyatt Hotel in New royalty has been
rescheduled to a assorted time.
king Pernock, the Company’s Chairman and CEO, is today regular to
inform on Tuesday, Sept 20, at 12:Ǡ p.m. Eastern Time.
The show module be webcast live, and a repetition module be acquirable on
the Investors country of the Company’s website at www.fibrocellscience.com.
About Fibrocell Science, Inc.
Fibrocell Science, Inc. (OTCBB:FCSC.ob – News) is a engineering consort convergent
on the utilization of regenerative radiophone therapy for aesthetic, scrutiny
and technological applications. Fibrocell Science is sworn to onward
the scientific, scrutiny and advertizement possibleness of autologous wound and
tissue, as substantially as its original cancellated processing profession and
manufacturing excellence. For added information, gratify meet www.fibrocellscience.com.
Contact:
Media
Marina Maher Communications
Jessica Morrison
(212) 485-6ᗦ
jmorrison@mahercomm.com
or
Investors
ICR, LLC
Sherry Bertner
Managing Director
(646) 277-1247
Sherry.Bertner@icrinc.com
This article manner of medical science